Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can kids with spina bifida multitask? new study finds out

NCT ID NCT06949475

Knowledge-focused Sponsor: Abant Izzet Baysal University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looked at how well children with myelomeningocele (a type of spina bifida) can perform two tasks at the same time, like moving blocks while tapping a rhythm, compared to children without the condition. Researchers tested 60 children aged 7-18 using simple hand and thinking tasks. The goal was to understand their daily challenges better, not to provide any treatment.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

60 people

The number who actually took part.

Started

May 2025

Finished

Dec 2025

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Children diagnosed with meningomyelocele and typically developing peers who agreed to participate in the study and met the inclusion criteria.

Ages

7 to 18 years

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: For children with meningomyelocele * To be between the ages of 7-18 * To have been diagnosed with meningomyelocele * To have scored 27 points or more on the modified mini mental test For children with typical developing * Being between the ages of 7-18 years * Having no typically developing musculoskeletal problems and volunteering to participate in the study * Not having a chronic neurological, cardiovascular or orthopedic disease * Having a score of 27 or above on the modified mini mental test Exclusion Criteria: For children with meningomyelocele * Not agreeing to participate in the study, * Having undergone surgery or Botolunium toxin administration within the last six months * Having suffered a fracture of the upper extremity within the last six months For children with typical developing * Having severe visual or hearing impairment * Having attention problems to the extent that they cannot understand the assessment instructions * Having a musculoskeletal, cardiovascular, pulmonary, metabolic or other disease severe enough to prevent participation in the study.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Meningomyelocele are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

myelomeningocele

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Meningomyelocele

Contacts and locations

Locations

  • Bolu abant Izzet Baysal University

    Merkez, Bolu, 14030, Turkey (Türkiye)